CryoLife Announces Release Date and Teleconference Call Details for 2020 Third Quarter Financial Results

Rhea-AI Summary

CryoLife, Inc. (NYSE: CRY) will announce its 2020 third quarter financial results on November 4, 2020, after market close. A teleconference will be held at 4:30 p.m. ET to discuss these results, led by CEO Pat Mackin, followed by a Q&A session. Interested parties can join via phone or access the live webcast on the company's website. A replay will be available until November 11, 2020. CryoLife specializes in medical devices for cardiac and vascular procedures and markets its products in over 100 countries.

Positive

• Scheduled earnings release may indicate proactive investor communication.
• Participation in global markets with products available in over 100 countries.

Negative

• None.

ATLANTA, Oct. 21, 2020 /PRNewswire/ -- CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today that 2020 third quarter financial results will be released on Wednesday, November 4, 2020 after the market closes.  On that day, the Company will hold a teleconference call and live webcast at 4:30 p.m. ET to discuss the results, followed by a question and answer session hosted by Pat Mackin, Chairman, President and Chief Executive Officer of CryoLife, Inc.

To listen to the live teleconference, please dial 201-689-8261 a few minutes prior to 4:30 p.m. ET.  A replay of the teleconference will be available November 4 through November 11, 2020 and can be accessed by calling (toll free) 877-660-6853 or 201-612-7415.  The conference number for the replay is 13712302.

The live webcast and replay can be accessed in the Investor Relations section of the CryoLife website at www.cryolife.com and selecting Webcasts & Presentations.  In addition, a copy of the earnings press release, which will contain financial and statistical information for the completed quarter and full year, can be accessed in the Investor Relations section of the CryoLife website.

About CryoLife, Inc.
Headquartered in suburban Atlanta, Georgia, CryoLife is a leader in the manufacturing, processing, and distribution of medical devices and implantable tissues used in cardiac and vascular surgical procedures focused on aortic repair.  CryoLife markets and sells products in more than 100 countries worldwide.  For additional information about CryoLife, visit our website, www.cryolife.com.

Contacts:
CryoLife	Gilmartin Group LLC
D. Ashley Lee	Brian Johnston / Lynn Lewis
Executive Vice President, Chief Financial Officer	Phone: 631-807-1986
and Chief Operating Officer	investors@cryolife.com
Phone: 770-419-3355

 

View original content to download multimedia:http://www.prnewswire.com/news-releases/cryolife-announces-release-date-and-teleconference-call-details-for-2020-third-quarter-financial-results-301156741.html

SOURCE CryoLife, Inc.

FAQ

When will CryoLife announce its Q3 2020 financial results?

CryoLife will announce its Q3 2020 financial results on November 4, 2020, after market close.

What time is the CryoLife teleconference for Q3 2020 results?

The teleconference for CryoLife's Q3 2020 results will be held at 4:30 p.m. ET on November 4, 2020.

How can I access the CryoLife Q3 2020 earnings call?

You can access the CryoLife Q3 2020 earnings call by dialing 201-689-8261 or via the live webcast on their website.

Will there be a replay of the CryoLife earnings call?

Yes, a replay of the CryoLife earnings call will be available from November 4 through November 11, 2020.